Our team

Celia BELLINE

Founder and Chief Executive Officer

Celia has over 15 years’ experience in the pharmaceutical industry. She worked as the global head of clinical trial logistics and supply chains in Sanofi R&D, was a permanent member of clinical strategic committees, and the Director of projects dealing with major chronic diseases associated with aging, where she developed her interest and expertise in hearing disorders. She trained at ESSEC and London Business Schools, in addition to holding several masters degrees in project management, industrial strategy and health environment.

Sylvie PUCHEU, Ph.D

Founder and Chief Scientific Officer

Dr. Pucheu has more than 23 years’ experience in academic research and the pharmaceutical industry. Before co-founding CILcare, she led an in-vivo pharmacology group working on tinnitus and hearing loss, alongside a number of the most highly-regarded academic experts in hearing disorders. She also led scientific teams at Sanofi, in the fields of cardiology, oncology, aging and hearing, as well as being deeply involved in their Ethics Committee. She is the author of several publications and of a patent.

Aurore MARIE

Senior Operations Manager and IMPLAN-T Project Director

Aurore specializes in in-vivo Pharmacology. With prior experience in neurosciences, her key competencies in the lab include electro-physiological measurements and brain surgery. Being particularly talented in complex surgical procedures, she is able to measure evoked potentials of the auditory function on chronic and acute protocols, several of which she developed herself. With her expertise in project management, she leads IMPLAN-T, a collaborative project aiming to accelerate the development of an intra-cochlear drug delivery system.

Cyrille SAGE, Ph.D

Director of US Operations

Dr. Sage has nearly 20 years of experience in inner hair cell research, conducting research projects both in France and in the US. During the past 5 years, he worked as Research Associate in gene therapy in Harvard Medical School, where he led a research project aiming at studying the genomic regulation of hair cells. He brings to CILcare extensive experience and know-how in inner ear biology including microsurgery (round window injection, intracochlear administration) cochleogram, and in vivo gene delivery.

Gaëlle NAERT, Ph.D

Chief Operations Officer

Gaëlle spent 13 years in France and Canada developing animals models to investigate the therapeutic avenues of major Central Nervous System disorders, such as depression and Alzheimer’s disease, neuro-inflammation processes which relate to otic and hearing diseases. Aside from developing drugs for CNS disorders, she has a wide range of project management and business development competencies, and is the author of many scientific communications and publications, as well as receiving many scholarships and awards.

Mark SELF

Executive Assistant

Mark has a broad set of skills which he uses to help CILcare in its new growth phase. Having lived in Europe and South America, he is fluent in English, French, and Spanish, with proficiency in Italian and Portuguese. Before joining CILcare, he held a number of different positions in varied domains such as education, gardening, and tourism. These experiences, combined with his strong capability to communicate and adapt, allow him to bring different techniques and perspectives to the table, helping in areas including communication and administration.

Marie PEYTAVY-IZARD

Marketing & Business Development Director

Marie has a broad range of innovation marketing and business development experience, and has played key roles in product launches in pharma, nutraceutical and cosmetic industries. Having previously led the global marketing strategy for a start-up company specializing in the development and marketing of health food ingredients for Type 2 diabetes prevention, as well as serving as Clinical Project Manager for the conduct of clinical trials in partnership with CRO’s, she is now responsible for the strategic direction of commercial activities for CILcare.

Wahid AWAD, Ph.D

Chief Business Officer

Dr. Awad has more than 14 years of international expertise in life sciences in both industry and academia. His experiences vary from research and teaching to business development, sales, leadership and management.  Having lived in four countries (Egypt, the Netherlands, the USA and currently France), he has a multicultural and multidisciplinary understanding of both academic and industrial life sciences environments. Wahid has passion for innovation, networking and connecting people to build collaborative relationships based on win-win outcomes.

Carolanne COYAT, Ph.D

R&D Project Manager

Carolanne’s expertise lies in auditory neuropathy. Over the past five years, she has been working on the evaluation of molecular and cellular mechanisms responsible for sensorineural and age-related hearing loss. At CILcare, Dr. Coyat brings her expertise to the pharmacokinetics platform, along with her knowledge of the latest advances in histology, including ribbon synapses counting, electrophysiological techniques, and biological sampling.

Marion SOUCHAL, Ph.D

R&D Project Manager

Marion’s expertise lies in highly advanced cochlear histology and electrophysiological measurement techniques. Before joining CILcare, she was working on the evaluation of molecular and cellular mechanisms responsible for drug-induced and age-related hearing loss. Dr. Souchal has strong technical competence in histology, including immunohistochemistry, ribbon synapse counting, and biological sampling.

Paul GRATIAS

Ph.D Student

Paul is currently pursuing his PhD in the field of Health and Biology at the University of Montpellier. He is developing and characterizing a new rodent model for impulse noise-induced auditory neuropathy. This innovative project is achieved by combining electrophysiology, fluorescent microscopy and behavioural experimentation.

Lise BYELYAYEVA

Business Developer

Lise is passionate about finding synergies within the field and building strong relationships. Her background in Neuroscience and business skills help her to understand the challenges of drug development for hearing indications and to find solutions to bring the innovation to patients.

Thibault ROCCHI

Marketing and Business Development Assistant

Thibault gathers a broad range of skills as he is working on business development, marketing, and communication at CILcare. He has spent years developing a scientific and technical background in physics and engineering, as well as working for both academic and private R&D labs. His scientific and multicultural experiences allow him to have a deep and concrete understanding of the needs in the R&D field.

Thibault is currently strengthening his skillset through a vocational Technical & Business Bachelor’s degree at CILcare.

Mathieu SCHUE

Project Director, Drug Development and Translational Research

Mathieu has over 15 years of experience in life science research. Prior to joining CILcare, he managed R&D operations in a biotech company specialized in the development of therapeutic proteins to treat cystic fibrosis and chronic pancreatitis. He successfully brought drug candidates from preclinical to clinical phases and handled the preparation of regulatory documents to support Phase 2 CTA. Mathieu leads projects to define innovative development plan strategies of drug candidates specifically for ear disorders as well as identifying reference compounds in the various indications of hearing for CILcare’s clients.

Sebastien DIOT

R&D Project Manager, Research Scientist Assistant

Sébastien is specialized in histology, more precisely on the acquisition and analysis of images. Before joining CILcare, he worked on the mechanism of action of a new anti-cancer compound, and he also characterized biosensors to sense cancer activities. This background allowed him to get experienced in R&D project follow up. At CILcare, Sebastien is involved on histology and in-vivo experimentation.